Neuromodulation in the Management of Lower Urinary Tract Dysfunction: Current Best Practice, Innovation and the Future

Workshop 24

Workshop Schedule

16:30

Arun Sahai
Tom Marcelissen

16:40

Tom Marcelissen

16:50

Roger Roman Dmochowski

17:00

Marcio Augusto Averbeck

17:10

Arun Sahai

17:20

All

17:35

Arun Sahai

17:45

Marcio Augusto Averbeck

17:55

All

Aims & Objectives

Intermediate
90 minutes
Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction
Clinical
sacral neuromodulation posterior tibial nerve stimulation lower urinary tract symptoms
Urology, Urogynaecology and Female & Functional Urology, Basic Science

Sacral Neuromodulation (SNM) has had FDA approval for the management of overactive bladder (OAB) and chronic non obstructive urinary retention for greater than 20 years. Since then posterior tibial nerve stimulation was introduced and predominantly is used to treat refractory OAB. In recent years several innovative developments have taken place in this field with additional benefits. The purpose of this workshop is to review the current status of neuromodulation in managing lower urinary tract dysfunction with a particular focus on evidence published in the last 5-10 years, discuss ways of optimising neuromodulation for the benefit of patients, discuss the new innovations and where the technology is heading in the future.